Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast), covering 2012-03-08 to 2012-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females [Phase 1]